MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC

MLA

Kyoung Young Lee, et al. “MDSC Subtypes and CD39 Expression on CD8 + T Cells Predict the Efficacy of Anti‐PD‐1 Immunotherapy in Patients with Advanced NSCLC.” European Journal of Immunology, vol. 50, July 2020, pp. 1810–19. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....06515c07aed266f0e8ce1656e50c6465&authtype=sso&custid=ns315887.

APA

Kyoung Young Lee, Youjin Kim, Yeon Hee Bae, Yeong Chan Lee, Joon Young Hur, Jiae Koh, Boram Kim, Bo Mi Ku, Jin Seok Ahn, Se-Hoon Lee, Jong-Mu Sun, Hee Jin Cho, Keunchil Park, Mi Soon Kim, & Myung-Ju Ahn. (2020). MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC. European Journal of Immunology, 50, 1810–1819.

Chicago

Kyoung Young Lee, Youjin Kim, Yeon Hee Bae, Yeong Chan Lee, Joon Young Hur, Jiae Koh, Boram Kim, et al. 2020. “MDSC Subtypes and CD39 Expression on CD8 + T Cells Predict the Efficacy of Anti‐PD‐1 Immunotherapy in Patients with Advanced NSCLC.” European Journal of Immunology 50 (July): 1810–19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....06515c07aed266f0e8ce1656e50c6465&authtype=sso&custid=ns315887.